Posted in | News | Materials Analysis

TacticID Handheld Raman Spectrometer Announced by B&W Tek

B&W Tek, an advanced instrumentation company that delivers lab quality Raman spectroscopy solutions through user-friendly mobile platforms, is proud to announce the enhanced TacticID handheld Raman spectrometer, featuring new functionality and safety.

The TacticID has been enhanced in three significant areas; user safety, mixture analysis, and library volume.

With safety as B&W Tek’s first priority, they have added two additional safety features: remote operation and scan delay.  With these features, users can now stand a safe distance away from potentially explosive materials while the TacticID does the rest.  Once the data is collected, this information can also be wirelessly transferred from the handheld unit to a computer.

The TacticID also features industry-leading advanced chemometric mixture analysis capabilities, so any additional compounds or ingredients within a sample are clearly identified on screen.

The TacticID-N model (targeted specifically for identifying narcotics) now boasts the largest available library of nearly 1,000 narcotics, pharmaceutical drugs, cutting agents and precursors.

For more information on the TacticID, visit: http://tacticid.com/index.php

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Metrohm AG. (2024, March 28). TacticID Handheld Raman Spectrometer Announced by B&W Tek. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=41543.

  • MLA

    Metrohm AG. "TacticID Handheld Raman Spectrometer Announced by B&W Tek". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=41543>.

  • Chicago

    Metrohm AG. "TacticID Handheld Raman Spectrometer Announced by B&W Tek". AZoM. https://www.azom.com/news.aspx?newsID=41543. (accessed November 21, 2024).

  • Harvard

    Metrohm AG. 2024. TacticID Handheld Raman Spectrometer Announced by B&W Tek. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=41543.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.